22 Jul 2011 08:20
Amphion Innovations plc
Directors' DealingsDirectors Receive Shares in Lieu of Fees
London and New York, 22 July 2011 - Amphion Innovations plc (the "Company") (LSE: AMP), the developer of medical and technology businesses, today announces that, as of 20 July 2011, the Company has issued 727,107 ordinary shares, representing 0.54% of the enlarged issued share capital, to certain of its Board members as their directors' fees for the first and second quarter to 30 June 2011, priced at 2.4p, being the average of the closing mid-market price for the five days leading up to the market close on 20 July 2011. Following this issue, the directors' shareholdings in the Company are as follows:
Director | Number of New Shares | Total Shareholding | Percentage of voting rights |
R. James Macaleer | 577,107 | 23,318,019 | 17.37% |
Gerard Moufflet | 150,000 | 450,000 | 0.34% |
Director, Anthony Henfrey waived his fees for the fourth quarter of 2010 and the first and second quarters of 2011.
Admission of the 727,107 new ordinary shares, ranking pari passu with the existing ordinary shares, is expected on 29 July 2011. Following this allotment the total issued share capital of the Company will increase to 134,225,850 ordinary shares with each share holding one voting right.
For further information please contact:
Amphion Innovations
Charlie Morgan:
+1 212 210 6224
Seymour Pierce Limited
Freddy Crossley/ Mark Percy
+44 020 7107 8000
Cardew Group
Tim Robertson
+44 020 7930 0777